bemarituzumab mfolfox6 in first-line advanced gastric/gastroesophageal junction adenocarcinoma
Published 3 years ago • 312 plays • Length 9:46Download video MP4
Download video MP3
Similar videos
-
1:35
fight: bemarituzumab mfolfox6 in first-line advanced gastric cancer
-
6:03
fight updates: bemarituzumab with folfox6 in fgfr2b advanced gastric/gastroesophageal junction ...
-
5:26
fight update: 1l bemarituzumab in fgfr2b gastric cancer
-
9:58
bemarituzumab plus folfox for advanced gastric/ge junction adenocarcinoma
-
3:22
bemarituzumab plus modified folfox6 for advanced gastric/ge junction adenocarcinoma
-
2:44
leap-015: lenvatinib pembrolizumab mfolfox6 in advanced/met gastroesophageal adenocarcinoma
-
4:29
bemarituzumab chemotherapy improve outcome in advance gastric and gastroesophageal junction cancer
-
4:06
bemarituzumab in solid tumors
-
1:52
iilustro: zolbetuximab, mfolfox6, and nivolumab combinations for gastrointestinal cancer
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
2:49
spotlight: zolbetuximab and m-folfox6 in cldn18.2 , her2- gej cancer
-
21:36
understanding, detecting, and treating gastroesophageal junction adenocarcinoma
-
1:23
zev wainberg, md, discusses the safety profile of bemarituzumab
-
7:47
highlights from asco gi 2021
-
9:44
adding first-line nivolumab to chemotherapy for advanced gastric, ge junction, and esophageal adenoc
-
3:02
updates from destiny-gastric 01
-
3:41
highlights in gastric cancer from esmo 2021
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
3:57
pembrolizumab plus 5-fu and cisplatin for first-line treatment in...